Takeaways: Power for powder innovation

Powdered supplements are projected to experience a 10.8 percent compound annual growth rate (CAGR) from 2016 to 2024, according to a 2018 report from Grand View Research. Succeeding in a thriving market with anticipated double-digit growth requires fine-tuned product development and formulation to ensure powdered supplements not only meet consumer expectations for quality, but also…

FDA’s willingness to explore reform of DSHEA draws mixed reactions

Consumer advocates, some Democratic lawmakers and industry trade organizations reacted differently to FDA’s willingness to examine possible reform of the Dietary Supplement Health and Education Act of 1994 (DSHEA). The divergent reactions reflect stark differences of opinion over the reputation of the dietary supplement industry and its 25-year-old regulatory regime. Peter Lurie, M.D., a former…

Inside the plant-based protein market

Consumer demand for sustainable products and knowledge of the health benefits of protein has driven the need for protein from plants, such as pea, hemp, rice, oats and beyond. A decade ago, soy-based veggie burgers were the primary plant protein-rich food found in a typical grocery store. Fast forward to 2019, and products made with…

CBD concentration matters

t’s true cannabidiol (CBD) is a drug. GW Pharmaceuticals went to great effort and expense to determine the clinical benefits of CBD. The specific, single-entity chemical is considered a drug because FDA approved it as one, and that is how the U.S. regulatory system operates. The regulatory system also renders items as drugs based exclusively…